SOBR Safe, Inc. (SOBR)
USD 0.9
(-10.0%)
USD 0.9
(-10.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.92 Million | -6.15 Million | -3.68 Million | -2.19 Million | -543.95 Thousand | -61.35 Thousand |
| Net Income | -10.21 Million | -12.35 Million | -7.87 Million | -29.98 Million | -1.25 Million | -558.96 Thousand |
| Depreciation & Amortization | 948.15 Thousand | 385.46 Thousand | 385.46 Thousand | 232.19 Thousand | 5920.00 | 80.00 |
| Deferred income taxes | -257.32 Thousand | - | 783.26 Thousand | 25.98 Million | -5920.00 | 46.01 Thousand |
| Stock-based compensation | 2.24 Million | 3 Million | 473.74 Thousand | 54.28 Thousand | 44.08 Thousand | 20.8 Thousand |
| Change in working capital | 595.03 Thousand | 929.91 Thousand | 472.86 Thousand | 105.29 Thousand | 336.43 Thousand | 430.62 Thousand |
| Other non-cash items | 497.56 Thousand | 3.45 Million | 2.06 Million | 1.41 Million | 327.68 Thousand | 80.00 |
| Investing Cash Flow | - | - | - | 951.00 | - | - |
| Investments in PPE | -4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | 951.00 | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 951.00 | - | - |
| Financing Cash Flow | 139.22 Thousand | 13.85 Million | 4.33 Million | 1.74 Million | 1.22 Million | 61.3 Thousand |
| Debt repayment | -1.67 Million | -3.29 Million | -4.23 Million | -41.66 Thousand | -186.62 Thousand | -61.3 Thousand |
| Dividends payments | - | -5 Million | -107.88 Thousand | -107.88 Thousand | - | - |
| Common Stock Repurchased | - | - | - | 29.22 Million | - | - |
| Common Stock Issuance | 373.98 Thousand | 16 Million | 107.72 Thousand | 1.7 Million | 39 Thousand | - |
| Other Financing Activities | -1.53 Million | 6.14 Million | -275 Thousand | -29.03 Million | 1.37 Million | 61.3 Thousand |
| Accounts receivables | 1918.00 | -30.32 Thousand | - | - | - | - |
| Accounts payables | 382.7 Thousand | -127.18 Thousand | 168.84 Thousand | 113.15 Thousand | 22.16 Thousand | -79.13 Thousand |
| Inventory | -127.28 Thousand | -176.03 Thousand | -39.46 Thousand | - | - | - |
| Other working capital | 720.41 Thousand | 1.26 Million | 343.47 Thousand | -7860.00 | 314.26 Thousand | 509.76 Thousand |
| Cash at beginning of period | 8.57 Million | 882.26 Thousand | 232.84 Thousand | 681.75 Thousand | 89.00 | 142.00 |
| Cash at end of period | 2.79 Million | 8.57 Million | 882.26 Thousand | 232.84 Thousand | 681.75 Thousand | 89.00 |
| Capital Expenditure | -4.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.78 Million | 7.69 Million | 649.42 Thousand | -448.91 Thousand | 681.67 Thousand | -53.00 |
| Free Cash Flow | -5.92 Million | -6.15 Million | -3.68 Million | -2.19 Million | -543.95 Thousand | -61.35 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.07 Million | -2.5 Million | -2.54 Million | -10.21 Million | -2.19 Million | -2.87 Million |
| Depreciation & Amortization | 96.36 Thousand | 96.36 Thousand | 241.4 Thousand | 385.46 Thousand | 96.36 Thousand | 96.36 Thousand |
| Deferred income taxes | - | - | -402.38 Thousand | -257.32 Thousand | -509.99 Thousand | 74.67 Thousand |
| Stock-based compensation | 185.9 Thousand | 214.39 Thousand | 409.19 Thousand | 2.24 Million | 509.99 Thousand | 627.76 Thousand |
| Change in working capital | -166.28 Thousand | -96.74 Thousand | 368.1 Thousand | 977.73 Thousand | -3629.00 | 276.77 Thousand |
| Other non-cash items | 366.11 Thousand | 838 Thousand | 702.3 Thousand | 3.43 Million | 662.26 Thousand | 125.18 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.42 Million | - | -111.36 Thousand | 139.22 Thousand | -109.03 Thousand | -940.83 Thousand |
| Debt repayment | - | - | 111.36 Thousand | -139.22 Thousand | -109.03 Thousand | -940.83 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.78 Million | - | - | 373.98 Thousand | - | - |
| Other Financing Activities | -360.75 Thousand | - | - | -1.53 Million | -109.03 Thousand | -940.83 Thousand |
| Accounts receivables | -9661.00 | -47.00 | -1538.00 | 1918.00 | 5394.00 | -1290.00 |
| Accounts payables | -112.98 Thousand | 107.07 Thousand | 276.64 Thousand | 382.7 Thousand | -235.37 Thousand | 143.26 Thousand |
| Inventory | 38.66 Thousand | 22.17 Thousand | -75.56 Thousand | -127.28 Thousand | -3854.00 | -13.62 Thousand |
| Other working capital | -82.29 Thousand | -225.95 Thousand | 168.56 Thousand | 720.41 Thousand | 230.2 Thousand | 148.42 Thousand |
| Cash at beginning of period | 1.33 Million | 2.79 Million | 4.12 Million | 8.57 Million | 5.67 Million | 8.29 Million |
| Cash at end of period | 2.16 Million | 1.33 Million | 2.79 Million | 2.79 Million | 4.12 Million | 5.67 Million |
| Capital Expenditure | 4.00 | - | -2.00 | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 830.15 Thousand | -1.45 Million | -1.33 Million | -5.78 Million | -1.55 Million | -2.61 Million |
| Free Cash Flow | -1.59 Million | -1.45 Million | -1.22 Million | -5.92 Million | -1.44 Million | -1.67 Million |
FDA
ESCORP
5512
S24
EDRVF
CAAOF